SCHEMBL27214288

SCHEMBL27214288

NC(=O)c1cccnc1S(=O)(=O)Nc1cccc2cccnc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 11/20 0.59
▸ PARP1 P09874 1/20 0.58
▸ TDP1 Q9NUW8 8/20 0.58
▸ GLO1 Q04760 7/20 0.58
▸ NFKBIA P25963 3/20 0.58
▸ AGTR1 P30556 2/20 0.58
▸ G6PD P11413 1/20 0.58
▸ METAP2 P50579 1/20 0.58
▸ METAP1 P53582 1/20 0.58
▸ PAX8 Q06710 1/20 0.58
▸ ATM Q13315 1/20 0.58
▸ KMT2A Q03164 6/20 0.57
▸ MEN1 O00255 5/20 0.57
▸ RELA Q04206 2/20 0.56
▸ HTT P42858 2/20 0.55
▸ ALOX15 P16050 1/20 0.55
▸ MITF O75030 1/20 0.54
▸ S1PR4 O95977 1/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ LMNA P02545 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30925457 1.00 SLC40A1 (0.59) SLC40A1PARP1TDP1GLO1NFKBIA
SCHEMBL27214262 0.84 SLC40A1 (0.58) SLC40A1TDP1GLO1NFKBIAAGTR1
SCHEMBL30925520 0.84 SLC40A1 (0.58) SLC40A1TDP1GLO1NFKBIAAGTR1
SCHEMBL27214307 0.81 TDP1 (0.73) SLC40A1TDP1GLO1NFKBIAAGTR1
SCHEMBL11973157 0.81 SLC40A1 (0.73) SLC40A1TDP1GLO1NFKBIAAGTR1
SCHEMBL30925538 0.81 TDP1 (0.73) SLC40A1TDP1GLO1NFKBIAAGTR1
SCHEMBL7388562 0.81 MEN1 (0.70) SLC40A1PARP1TDP1NFKBIAKMT2A
SCHEMBL12598516 0.79 SLC40A1 (0.64) SLC40A1TDP1GLO1NFKBIAAGTR1
SCHEMBL30925443 0.79 SLC40A1 (0.77) SLC40A1TDP1GLO1NFKBIAAGTR1
SCHEMBL30925535 0.79 SLC40A1 (0.73) SLC40A1TDP1GLO1NFKBIAAGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240148744-A1 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES ZOETIS LLC 2024-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240148744-A1 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES ARSA, MRPS2, SULT2A1 SLC40A1 3357/4885PARP1 4608/4885TDP1 4247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback